Daiwa Securities Group
GPCR icon

Daiwa Securities Group’s Structure Therapeutics GPCR Stock Holding History

Daiwa Securities Group’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-186
Closed -$13K – 1287
2025
Q4 		$13K Sell
186
-40
-18% -$1.63K ﹤0.01% 1172
2025
Q3 		$6K Hold
226
– – ﹤0.01% 1189
2025
Q2 		$5K Hold
226
– – ﹤0.01% 1158
2025
Q1 		$4K Hold
226
– – ﹤0.01% 1147
2024
Q4 		$6K Hold
226
– – ﹤0.01% 1153
2024
Q3 		$10K Buy
226
+73
+48% +$2.82K ﹤0.01% 1130
2024
Q2 		$6K Hold
153
– – ﹤0.01% 1187
2024
Q1 		$7K Hold
153
– – ﹤0.01% 1185
2023
Q4 		$6K Buy
+153
New +$8.77K ﹤0.01% 1192

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Daiwa Securities Group's GPCR Position: Q1 2026 in Review

Daiwa Securities Group sold out of Structure Therapeutics (GPCR) in Q1 2026, closing a stake of 186 shares — an estimated $13K sold.

Daiwa Securities Group first reported a position in GPCR in Q4 2023 and held it in 9 quarters. The position peaked at $13K in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • Daiwa Securities Group reported no remaining Structure Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 186 Structure Therapeutics shares in Q1 2026, an estimated $13K.
  • Daiwa Securities Group first reported a position in Structure Therapeutics in Q4 2023 and held it in 9 quarters.
  • Daiwa Securities Group's Structure Therapeutics position peaked at $13K in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.